---
title: "CRSP.US (CRSP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRSP.US/news.md"
symbol: "CRSP.US"
name: "CRSP.US"
parent: "https://longbridge.com/en/quote/CRSP.US.md"
datetime: "2026-05-21T06:20:26.457Z"
locales:
  - [en](https://longbridge.com/en/quote/CRSP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRSP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRSP.US/news.md)
---

# CRSP.US (CRSP.US) — Related News

### ["Wood" latest holdings released: reduced positions in Tesla and NVIDIA!](https://longbridge.com/en/news/286703114.md)
*2026-05-18T02:22:04.000Z*
> Famous investor Cathie Wood ("Wood Sister") latest holdings show a reduction in Tesla and NVIDIA, with a portfolio value

### [Nat Biotechnol: Replacing the Navigation for Gene "Scissors": The team led by Xing Yiming from the Hong Kong University of Science and Technology successfully modified Cas12a to precisely control RNA using DNA instructions](https://longbridge.com/en/news/286659591.md)
*2026-05-17T03:25:22.000Z*
> The team led by Xing Yiming from the Hong Kong University of Science and Technology published research in Nature Biotech

### [CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms](https://longbridge.com/en/news/286625162.md)
*2026-05-16T00:12:19.000Z*
> CRISPR Therapeutics is entering a 'second phase' as it moves beyond the launch of CASGEVY, with plans to generate data f

### [CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/286048365.md)
*2026-05-12T06:48:06.000Z*
> CRISPR Therapeutics AG (NASDAQ:CRSP) has received an average analyst rating of "Moderate Buy" from eighteen analysts. Th

### [Intellia Therapeutics (NASDAQ:NTLA) Announces Earnings Results](https://longbridge.com/en/news/285972862.md)
*2026-05-11T16:20:42.000Z*
> Intellia Therapeutics (NASDAQ:NTLA) reported quarterly earnings of ($0.81) per share, exceeding estimates of ($0.92) by 

### [FY2028 EPS Estimates for CRSP Decreased by Analyst](https://longbridge.com/en/news/285376680.md)
*2026-05-06T12:21:34.000Z*
> CRISPR Therapeutics AG (NASDAQ:CRSP) has seen a decrease in FY2028 earnings per share estimates from Brookline Capital M

### [Crispr Therapeutics AG (CRSP) Gets a Buy from Piper Sandler](https://longbridge.com/en/news/285198432.md)
*2026-05-05T11:35:38.000Z*
> Piper Sandler analyst Edward Tenthoff has reiterated a Buy rating on Crispr Therapeutics AG (CRSP) with a price target o

### [Chardan Capital Remains a Buy on Crispr Therapeutics AG (CRSP)](https://longbridge.com/en/news/285145408.md)
*2026-05-05T02:35:34.000Z*
> Chardan Capital has reiterated a Buy rating on Crispr Therapeutics AG (CRSP) with a price target of $76.00. Analyst Geul